• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIATORR® TIPS ENDOPROSTHESIS; SHUNT, PORTOSYSTEMIC, ENDOPROSTHESIS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIATORR® TIPS ENDOPROSTHESIS; SHUNT, PORTOSYSTEMIC, ENDOPROSTHESIS Back to Search Results
Catalog Number PT107275
Device Problem Pressure Problem (3012)
Patient Problems Bradycardia (1751); Cardiac Arrest (1762); Low Oxygen Saturation (2477)
Event Date 09/01/2013
Event Type  Injury  
Manufacturer Narrative
A device lot number was not provided; therefore, a review of the manufacturing records cannot be performed.The device remains implanted.Literature citation: (b)(6) cardiac arrest after transjugular intrahepatic porto-systemic shunt creation in a (b)(6) year-old patient with end stage liver disease secondary to cystic fibrosis.Journal of gastrointestinal and liver disease 2013;3:362.
 
Event Description
This information was received through literature article "cardiac arrest after transjugular intrahepatic porto-systemic shunt creation in a (b)(6)-old patient with end stage liver disease secondary to cystic fibrosis" published in journal of gastrointestinal and liver disease, (b)(6) 2013.The article reports that following deployment of a 10mm gore viatorr tips endoprosthesis during a transjugular intrahepatic portosystemic shunt procedure, hemodynamic measurement showed a severe increase in the right atrial pressure.Directly following completion of the procedure the patient's oxygen saturation decreased progressively with severe bradycardia and cardiac arrest.Adrenaline intravenous infusion, cardiac massage and administration of 20ppm of inhaled nitric oxide were performed for around two minutes until spontaneous cardiac activity was restored.The patient was transferred to the intensive care unit for 24 hours.Eight days following this postprocedural complication, the patient was discharged home.The patient no longer requires paracentesis for ascites given that it has resolved in 6 months of follow up.
 
Manufacturer Narrative
A device lot number was provided by the corresponding author.A review of the manufacturing records verified the lot was processed normally and all pre-release specifications were met.(b)(4).Additional information received from the corresponding author: tips creation, although very risky in this kind of patient, was proposed as a bridge to transplantation.Tips creation in cf patients is a very unusual procedure with very few cases reported.I do not think viator stent was in any case responsible of the complication, i think it would have be the same using a wallstent or other covered stent.In our patient the presence of subclinical pulmonary hypertension was likely responsible for this major immediate complication.The hypertrophy of the muscular layer of the pulmonary arteries secondary to chronic hypoxemia, might have reduced the capacity of the pulmonary vessels and right heart to compensate for the acute volume overload secondary to tips creation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIATORR® TIPS ENDOPROSTHESIS
Type of Device
SHUNT, PORTOSYSTEMIC, ENDOPROSTHESIS
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL PHOENIX 1 B/P
32360 n. north valley parkway
phoenix AZ 85085
Manufacturer Contact
marci stewart
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key5054906
MDR Text Key24996252
Report Number3007284313-2015-00095
Device Sequence Number1
Product Code MIR
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
P040027
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,litera
Reporter Occupation Physician
Report Date 09/10/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/03/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/28/2015
Device Catalogue NumberPT107275
Device Lot Number10173080
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/17/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age28 YR
-
-